The variance in operating expenses was driven by lower professional fees by $12,000,000 in advisory expenses from corporate initiatives, primarily related to regulatory compliance and transformation efforts and an €8,000,000 reversal of an accrual related to regulatory examination fees in BPPR. During Q3, we incurred $4,000,000 transformation related expenses compared to $7,000,000 last quarter. Our transformation effort is progressing as planned, but due to the stage of execution of various major projects, The timing of some of the expenses will be somewhat delayed. Also, the decision to use in house resources to repurpose Previously planned consulting fees into longer term investment or capitalizable initiatives has resulted in a lower than forecasted expense. As a result, we now expect transformation expenses for 2023 to be approximately 30,000,000 down from our prior guidance of $50,000,000 We expect Q4 expenses to be approximately 475,000,000 Normalizing for the $23,000,000 non cash goodwill impairment, total expenses for 2023 Will be around $1,820,000,000 or $50,000,000 better than our original guidance, driven by lower transformation expenses and cost control initiatives undertaken during the year.